Variants in GCH1 can reduce BH4 levels, impaire dopamine synthesis, and disrupt dopaminergic nigrostriatal neurotransmission, leading to, parkinson’s disease, and other related disorders [9, 12]. Here, GCH1 is linked to Parkinson disease.